Biogen

Biogen

Team Size
1–10
Employees
Forbes Tech

Biogen Exec Denies That New Alzheimer’s Medicine Will Overwhelm Medicare — But Experts Disagree

Quartz

Biogen is pricing aducanumab at $56,000 but it's worth less than $10,000

CNBC , GeekWire

Biogen shares surge 38% after FDA approves Alzheimer's drug, the first new therapy for the disease in nearly two decades

MedCity News , The Boston Globe

Biogen teams up with Ginkgo Bioworks in gene therapy manufacturing pact

MedCity News

Biogen, Apple to launch virtual study on cognitive health

Reuters Tech News

Breakingviews - Biogen gets $17 bln jolt of Alzheimer's hope

Reuters Tech News

U.S. experts to review Biogen drug that could be first new Alzheimer's treatment in decades

Xconomy

Biogen's AdComm Meeting Will Test FDA's "Substantial Evidence" Flexibility

Xconomy

Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More

Xconomy

Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds

Pulse 2.0

Morgan Stanley Upgrades Biogen (BIIB) Stock

neurons.AI

Iqvia CFO leaves for Biogen: Here’s how much more he’ll be paid

Xconomy

Biogen Alzheimer’s Drug in FDA's Court Following Completion of Filing

neurons.AI

Own Biogen For Long-Term Safety And Growth

neurons.AI

Biogen and MIT Launch New Virtual Learning Lab for High School Students Historically …

Xconomy

Biogen Pushes Finalized Filing for Alzheimer’s Drug to Third Quarter

Quartz , Bloomberg Technology

Biogen’s anticipated Alzheimer’s drug is still months away

MedCity News

Biogen shares fall as company pushes back Alzheimer’s drug filing

the home of AI info

Biogen, Sangamo collaborate for gene regulation therapies in neurological ailments

U.S.

Biotechnology trade group taps former Biogen CEO as its coronavirus czar